Konofal Eric 13D/13G Filings for NLS Pharmaceutics AG (NLSP)

Konofal Eric 13D and 13G filings for NLS Pharmaceutics AG:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2023-02-13
7:32 pm
Purchase
2022-12-3113GNLS Pharmaceutics AG
NLSP
Konofal Eric2,563
3.200%
13increase
(+0.49%)
Filing
2022-02-24
06:06 am
Purchase
2021-12-3113GNLS Pharmaceutics AG
NLSP
Konofal Eric2,550
6.300%
2,550increase
(New Position)
Filing